The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Noninvasive response parameters (molecular imaging [FDG-PET/CT] and molecular expression of VEGFR) to neoadjuvant oxaliplatin and chemoradiation in rectal cancer as prognostic factors in surveillance and correlation with pathologic response.
Dolores De La Mata Moya
No relevant relationships to disclose
Felipe A. Calvo
No relevant relationships to disclose
Marina Gomez Espi
No relevant relationships to disclose
Jose Luis Carreras
No relevant relationships to disclose
Emilio Alvarez
No relevant relationships to disclose